Island Pharmaceuticals (ASX:ILA) FCF Yield % : -35.24 (As of May. 25, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Island Pharmaceuticals FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Island Pharmaceuticals's Trailing 12-Month Free Cash Flow is A$-2.73 Mil, and Market Cap is A$7.74 Mil. Therefore, Island Pharmaceuticals's FCF Yield % for today is -35.24%.

The historical rank and industry rank for Island Pharmaceuticals's FCF Yield % or its related term are showing as below:

ASX:ILA' s FCF Yield % Range Over the Past 10 Years
Min: -56.85 Med: 0 Max: 0
Current: -35.24

ASX:ILA's FCF Yield % is ranked worse than
69.54% of 1553 companies
in the Biotechnology industry
Industry Median: -14.53 vs ASX:ILA: -35.24

Island Pharmaceuticals's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

Island Pharmaceuticals FCF Yield % Historical Data

The historical data trend for Island Pharmaceuticals's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Island Pharmaceuticals FCF Yield % Chart

Island Pharmaceuticals Annual Data

Trend

Jun21

Jun22

Jun23

FCF Yield %

-4.14

-15.94

-34.97

Island Pharmaceuticals Semi-Annual Data
	Jun20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	Get a 7-Day Free Trial			-6.95	-19.65	-17.63	-35.62	-35.00

Competitive Comparison of Island Pharmaceuticals's FCF Yield %

For the Biotechnology subindustry, Island Pharmaceuticals's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Island Pharmaceuticals's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Island Pharmaceuticals's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Island Pharmaceuticals's FCF Yield % falls into.

Island Pharmaceuticals FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Island Pharmaceuticals's FCF Yield % for the fiscal year that ended in Jun. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-2.7	/	7.7204804586
	=	-34.97%

Island Pharmaceuticals's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-1.351	*	2	/	7.7204804586
	=	-35.00%

Island Pharmaceuticals FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Island Pharmaceuticals FCF Yield % Related Terms

Thank you for viewing the detailed overview of Island Pharmaceuticals's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Island Pharmaceuticals (ASX:ILA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Island Pharmaceuticals Ltd (ASX:ILA) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

697 Burke Road, Suite 201, Camberwell, VIC, AUS, 3124

Website

https://www.islandpharmaceuticals.com

Island Pharmaceuticals Ltd is a drug research and repurposing company focused on developing preventative or therapeutic drugs for viral infections. Its lead asset ISLA-101 is a drug with a well-established safety profile, being repurposed for the prevention and treatment of dengue fever and another mosquito (or vector) borne diseases.

Island Pharmaceuticals (ASX:ILA) Headlines

No Headlines